Molnupiravir for intra-household prevention of COVID-19: The MOVe-AHEAD randomized, placebo-controlled trial

Sady Alpizar(Florida Craniofacial Institute), José Accini(Universidad del Norte), Duane C. Anderson(Excel Diagnostics Imaging), Basem Eysa(National Water Research Center), Isaí Medina-Piñón(Huaihua University), Norio Ohmagari(National Center for Global Health and Medicine), Мykola Ostrovskyy(Ivano-Frankivsk National Medical University), Angela Aggrey-Amable(Merck & Co., Inc., Rahway, NJ, USA (United States)), Karen Beck(Merck & Co., Inc., Rahway, NJ, USA (United States)), Dana Byrne(Merck & Co., Inc., Rahway, NJ, USA (United States)), Staci Grayson(Merck & Co., Inc., Rahway, NJ, USA (United States)), Peggy Hwang(Merck & Co., Inc., Rahway, NJ, USA (United States)), Julia Lonchar(Merck & Co., Inc., Rahway, NJ, USA (United States)), Julie Strizki(Merck & Co., Inc., Rahway, NJ, USA (United States)), Yayun Xu(Merck & Co., Inc., Rahway, NJ, USA (United States)), Amanda Paschke(Merck & Co., Inc., Rahway, NJ, USA (United States)), Carisa S De Anda(Merck & Co., Inc., Rahway, NJ, USA (United States)), P.S. Sears(Merck & Co., Inc., Rahway, NJ, USA (United States))
Journal of Infection
September 9, 2023
Cited by 22Open Access
Full Text

Abstract


Related Papers

No related papers found

Powered by citation graph analysis